CXCR2 and breast cancer: MSCs activated by IL-1β secrete other inflammatory cytokines, such as CXCL1 [14-16], which is implicated through signaling through CXCR2 expressed on breast cancer cells in the dissemination, poor patient prognosis, chemo-resistance, and metastasis [14, 17].